Select Page

Home / Mon 05 Aug 2024 Market Recap

05 Aug 2024: Nifty 50 Plunges 2.7%: Metal & Auto Stocks Lead Selloff as JSW Steel (-7.87%) & Tata Motors (-5.62%) Tumble

05 Aug 2024: Nifty 50 Plunges 2.7%: Metal & Auto Stocks Lead Selloff as JSW Steel (-7.87%) & Tata Motors (-5.62%) Tumble
Show Table of Contents

Top Indices Performance Overview

Stock Close Range
NIFTY 50 ₹24,051.8 (-2.7%) ₹23,893.69 – ₹24,350.05
NIFTY BANK ₹50056 (-2.53%) ₹49,719.1 – ₹50,747.55
NIFTY FIN SERVICE ₹22,751.19 (-2.64%) ₹22598 – ₹23,086.15
NIFTY IT ₹38,435.94 (-3.26%) ₹37,829.1 – ₹39,044.69
NIFTY AUTO ₹24,706.5 (-3.92%) ₹24,509.25 – ₹25,150.5
NIFTY ENERGY ₹42,640.89 (-3.82%) ₹42,284.6 – ₹43,594.44

Nifty 50 Performance Overview

The Nifty 50 started the day at ₹24,323.69, showcasing a bit of a roller coaster ride. It dipped to a low of ₹23,893.69 before climbing to a high of ₹24,350.05. By the closing bell, the index settled at ₹24,051.8, down 2.7% for the day.

This movement was influenced by a mix of top gainers and losers, which you can find in the table below.

Nifty 50 Top Gainers

Stock Close Range
Hindustan Unilever ₹2722 (1.09%) ₹2,666.19 – ₹2742
Nestle India ₹2,514.5 (0.77%) ₹2,475.05 – ₹2,528.89
Tata Consumer Products ₹1202 (0.69%) ₹1151 – ₹1,213.58
HDFC Life ₹710.9 (0.49%) ₹690.04 – ₹713.9

Nifty 50 Top Losers

Stock Close Range
JSW Steel ₹861 (-7.87%) ₹854.15 – ₹884
Tata Motors ₹1,015.45 (-7.41%) ₹1,014.04 – ₹1065
Tata Steel ₹149.33 (-5.62%) ₹149 – ₹154
Hindalco ₹613.5 (-5.33%) ₹609.25 – ₹633.84
SBI ₹810 (-4.47%) ₹800 – ₹831.34

Nifty 50 Stocks To Watch for Tomorrow

Nestle India (Bullish Pattern)

  • Performance Overview: In the last 25 trading days, Nestle India closed higher 11 times and lower 14 times.
  • Recent Trend: Nestle India has been on a 3-day winning streak, with no closing losses since Wednesday, July 31, 2024.
  • Returns: Over the past 25 trading days, Nestle India generated a return of -1.77%. This means an investment of ₹10,000 would be worth ₹9,823 today.
  • Financial Insight: Over the past year, Nestle India generated revenue of ₹19,665.02 Crore and achieved a profit of ₹3,244.46 Crore.
  • As of Monday, August 5, 2024, Nestle India has a Market Capital of ₹2,40,846.42 Crore.
  • Summary: Nestle India shows a strong bullish pattern. Keep an eye on its price movements for both short-term and long-term growth potential. Check out Nestle India Target for Tomorrow and Nestle India Targets for 2024 & 2025 for more insights.

Nestle India Financial Performance

Metric Value Description
Market Capital 2,40,846.42 Crore Market valuation of Nestle India’s shares.
Revenue (TTM) 19,665.02 Crore Total revenue generated by Nestle India over the past twelve months.
Net Income (TTM) +3,244.46 Crore Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin 20.55% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin 16.49% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+3.3% Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+6.9% Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
10.31 Company’s total debt divided by total shareholder equity.
Total Debt 344.76 Crore Sum of Nestle India’s current & long-term financial obligations.
Total Cash 798.84 Crore Total amount of liquid funds available to Nestle India.
Beta 0.06 Beta is less than 1 indicating that the Nestle India’s price is less volatile than the market.

GRASIM (Bearish Pattern)

  • Performance Overview: Over the past 25 trading days, GRASIM’s stock has closed lower 15 times and higher 10 times.
  • Recent Trend: GRASIM has been on a downward trend, closing lower for the past six trading days, with the last green day being Friday, July 26, 2024.
  • Returns: In the last 25 trading sessions, GRASIM has yielded a return of -1.92%. This means an investment of ₹10,000 would be worth ₹9,808 today.
  • Financial Insight: Over the last year, GRASIM has generated revenue of ₹1,30,978.48 Crore and earned a profit of ₹5,624.48 Crore.
  • As of Monday, August 5, 2024, GRASIM has a Market Capital of ₹1,83,406.48 Crore.
  • Summary: GRASIM is currently in a bearish phase. Investors should keep a close eye on its performance, particularly the GRASIM Target for Tomorrow and GRASIM Targets for 2024 & 2025.

GRASIM Financial Performance

Metric Value Description
Market Capital 1,83,406.48 Crore Market valuation of GRASIM’s shares.
Revenue (TTM) 1,30,978.48 Crore Total revenue generated by GRASIM over the past twelve months.
Net Income (TTM) +5,624.48 Crore Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin 17.41% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin 4.29% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+12.7% Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+0.1% Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
100.1 Company’s total debt divided by total shareholder equity.
Total Debt 1,39,077.27 Crore Sum of GRASIM’s current & long-term financial obligations.
Total Cash 22,122.05 Crore Total amount of liquid funds available to GRASIM.
Beta 0.55 Beta is less than 1 indicating that the GRASIM’s price is less volatile than the market.

Nifty 500 Performance Overview

The Nifty 500 kicked off the day at ₹22,772.55, showing a bit of a roller coaster ride throughout the session. It dipped to a low of ₹22,397.69 before reaching a peak of ₹22,868.34. The index eventually closed at ₹22,542.44, down 3.09% from its starting point.

The movement was influenced by the top gainers and losers, which you can find in the table below.

Nifty 500 Top Gainers

Stock Close Range
Lux Industries ₹2299 (10.57%) ₹2,039.34 – ₹2300
Cera Sanitaryware ₹9,436.7 (5.56%) ₹8760 – ₹9487
Glenmark Life Sciences ₹932 (5.42%) ₹851.25 – ₹954.59
Dr. Lal Path labs ₹3158 (1.98%) ₹3,055.35 – ₹3,172.19
Vijaya Diagnostic Centre ₹800.95 (1.86%) ₹763.79 – ₹805

Nifty 500 Top Losers

Stock Close Range
Shree Renuka Sugars ₹45.55 (-12.68%) ₹45.22 – ₹47.35
Redington ₹190.25 (-11.38%) ₹190 – ₹200
RCF ₹196 (-10.87%) ₹195.32 – ₹207.45
REC ₹578 (-10%) ₹572.65 – ₹597.2
RBL Bank ₹214.28 (-9.64%) ₹211.73 – ₹222.82

Nifty 51 to 500 Stocks To Watch for Tomorrow

Ajanta Pharma (Bullish Pattern)

  • Performance Overview: In the last 24 trading sessions, Ajanta Pharma has closed higher 17 times and lower 7 times.
  • Recent Trend: Ajanta Pharma has been on a 3-day winning streak, without a single day closing lower since Tuesday, July 16, 2024.
  • Returns: Ajanta Pharma delivered a 24.3% return in the last 24 trading sessions, meaning an investment of ₹10,000 would have grown to ₹12,429.99.
  • Financial Insight: Over the past 12 months, Ajanta Pharma has generated revenue of ₹4,332.58 Crore and achieved a profit of ₹853.82 Crore.
  • As of Monday, August 5, 2024, Ajanta Pharma has a Market Capital of ₹35,341.25 Crore.
  • Summary: Ajanta Pharma presents a strong bullish pattern. Investors should keep an eye on its price movements for both short-term and long-term growth opportunities: Checkout Ajanta Pharma Target for Tomorrow and Ajanta Pharma Targets for 2024 & 2025.

Ajanta Pharma Financial Performance

Metric Value Description
Market Capital 35,341.25 Crore Market valuation of Ajanta Pharma’s shares.
Revenue (TTM) 4,332.58 Crore Total revenue generated by Ajanta Pharma over the past twelve months.
Net Income (TTM) +853.82 Crore Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin 25.88% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin 19.7% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+12.1% Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+18.09% Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
1.03 Company’s total debt divided by total shareholder equity.
Total Debt 36.84 Crore Sum of Ajanta Pharma’s current & long-term financial obligations.
Total Cash 459.54 Crore Total amount of liquid funds available to Ajanta Pharma.
Beta 0.04 Beta is less than 1 indicating that the Ajanta Pharma’s price is less volatile than the market.

Astral (Bearish Pattern)

  • Performance Overview: Over the last 25 trading days, Astral has ended the day lower than the previous day 18 times, and higher 7 times.
  • Recent Trend: Astral has been on a downward trend for the past 6 days, with no positive closing since Friday, July 26, 2024.
  • Returns: In the last 25 trading days, Astral has delivered a return of -11.54%. This means an investment of ₹10,000 would have become ₹8,846.
  • Financial Insight: In the past 12 months, Astral has generated revenue of ₹5,641.39 Crore and a profit of ₹546.1 Crore.
  • As of Monday, August 5, 2024, Astral has a Market Capital of ₹57,229.63 Crore.
  • Summary: Astral is currently facing a bearish trend. It’s a good idea for investors to stay informed and monitor the situation closely. You might want to check out the Astral Target for Tomorrow and Astral Targets for 2024 & 2025 for additional insights.

Astral Financial Performance

Metric Value Description
Market Capital 57,229.63 Crore Market valuation of Astral’s shares.
Revenue (TTM) 5,641.39 Crore Total revenue generated by Astral over the past twelve months.
Net Income (TTM) +546.1 Crore Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin 15.1% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin 9.68% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+7.9% Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
-11.7% Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
3.65 Company’s total debt divided by total shareholder equity.
Total Debt 119.4 Crore Sum of Astral’s current & long-term financial obligations.
Total Cash 609.5 Crore Total amount of liquid funds available to Astral.
Beta 0.48 Beta is less than 1 indicating that the Astral’s price is less volatile than the market.

Top Stocks That Created a New All Time High Today

Top Large Cap Stocks That Created a New All Time High Today

Companies with Market Capital more than 20,000 Crores
Stock Close New All-Time High (ATH) Previous ATH Previous ATH Date
Ajanta Pharma 2841.85 (+0.47%) 2873.94 (+%) Thu 01 Jan 1970
Sun Pharma 1720.34 (-0.66%) 1758.00 (+7.58%) 1634.00 Thu 28 Mar 2024

Top Mid Cap Stocks That Created a New All Time High Today

Companies with Market Capital between 5,000 Crores to 20,000 Crores
Stock Close New All-Time High (ATH) Previous ATH Previous ATH Date
Black Box 565.25 (+1.13%) 584.00 (+%) Thu 01 Jan 1970
Blue Jet Healthcare 518.65 (+2.2%) 530.00 (+%) Thu 01 Jan 1970
Neuland Laboratories 10800.00 (-2.51%) 11800.00 (+55.05%) 7610.00 Tue 16 Apr 2024
PCBL 380.20 (+0.87%) 396.89 (+%) Thu 01 Jan 1970
Shakti Pumps 4907.00 (+4.69%) 4921.04 (+166.86%) 1844.00 Wed 24 Apr 2024

Top Small Cap Stocks That Created a New All Time High Today

Companies with Market Capital less than 5,000 Crores
Stock Close New All-Time High (ATH) Previous ATH Previous ATH Date
Ahmedabad Steelcraft 168.64 (+1.99%) 168.64 (+%) Thu 01 Jan 1970
Arrow Greentech 943.29 (+19.99%) 943.29 (+%) Thu 01 Jan 1970
Bits 6.79 (+1.95%) 6.79 (+%) Thu 01 Jan 1970
Ceenik Exports 1037.05 (+1.99%) 1037.05 (+102.86%) 511.20 Wed 24 Apr 2024
Chitradurga Spintex 341.79 (+1.99%) 341.79 (+57.58%) 216.89 Wed 24 Apr 2024

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. Connect on linkedin